Related Experiment Video
Updated: May 5, 2026

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
Published on: April 23, 2021
Cancer-associated adipocyte promote progression and immunosuppression in triple-negative breast cancer
Xichao Zhang1, Shenjie Zhong2, Shan Liu2
1School of Medical Laboratory, Shandong Second Medical University, Weifang, China.
Abstract:
Triple-negative breast cancer (TNBC) is characterized by highmetastatic potential and a lack of effective targeted therapies. Within the tumor microenvironment (TME) of TNBC, adipocyte can undergo transformation into cancer-associated adipocytes (CAA) through interactions with cancer cells; however, the specific role in the progress of TNBC is still not well described. This study aimed to investigate the impact of CAA on the malignant behavior of TNBC and its underlying mechanisms. CAA model was successfully established by co-culturing 3T3-L1-induced adipocytes with 4T1 cells, which exhibited characteristic features such as reduced lipid accumulation. Functional assays demonstrated that co-culture with CAA significantly enhanced the migration and invasion capabilities of 4T1 cells. In vivo experiments showed that co-injection of CAA with tumor cells accelerated primary tumor growth and promoted lung metastasis in mice. Mechanistic analysis revealed that in tumor tissues coexisting with CAA, E-cadherin expression was downregulated, accompanied by increased Ki67 expression and activation of the PI3K/AKT signaling pathway. Furthermore, CAA induces an immunosuppressive TME, characterized by elevated PD-L1 expression and reduced CD8+T cell infiltration. In conclusion, this study demonstrates that CAA promotes TNBC progression by activating epithelial-mesenchymal transition (EMT) and the PI3K/AKT pathway, as well as remodeling an immunosuppressive microenvironment, providing experimental insight into tumor-adipocyte interactions and identifying potential therapeutic targets.
Related Concept Videos
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Immunotherapy

